Table 2.
Mean level of risk factors within high-risk patients, not controlled for confounding.
| GP group, mean (95% CI), n | Practice nurse group, mean (95% CI), n | |||
|---|---|---|---|---|
| Baseline (T0) | After 1 year (T1) | Baseline (T0) | After 1 year (T1) | |
| Systolic blood pressure, mmHg | ||||
| All patients | 143 (140 to 145), 327 | 141 (138 to 143), 308 | 140 (138 to 142), 281 | 137 (135 to 139), 256 |
| Patients with high systolic blood pressure (≥140 mmHg) at T0 | 157 (154 to 159), 193 | 150 (146 to 153), 163 | 155 (153 to 158), 146 | 144 (141 to 147), 126) |
| Total cholesterol, mmol/l | ||||
| All patients | 5.0 (4.9 to 5.1), 302 | 5.1 (4.9 to 5.2), 277 | 5.1 (5.0 to 5.3), 272 | 4.9 (4.7 to 5.0), 219 |
| Patients with high total cholesterol (≥5 mmol/l) at T0 | 5.9 (5.8 to 6.0), 144 | 5.6 (5.4 to 5.7), 114 | 6.1 (5.9 to 6.3), 133 | 5.3 (5.1 to 5.5), 102 |
| LDL cholesterol, mmol/l | ||||
| All patients | 3.0 (2.9 to 3.1), 289 | 3.1 (2.9 to 3.2), 270 | 3.1 (2.9 to 3.2), 264 | 2.9 (3.0 to 3.3), 218 |
| Patients with high LDL cholesterol (≥2.5 mmol/l) at T0 | 3.5 (3.4 to 3.7), 189 | 3.3 (3.1 to 3.4), 148 | 3.6 (3.4 to 3.7), 180 | 3.1 (3.0 to 3.3), 131 |
| BMI, kg/m2 | ||||
| All patients | 26.9 (26.4 to 27.4), 248 | 27.0 (26.5 to 27.5), 281 | 28.0 (27.5 to 28.5), 251 | 27.6 (27.1 to 28.1), 235 |
| Patients with high BMI (≥25 kg/m2) at T0 | 28.7 (28.2 to 29.1), 171 | 28.4 (27.9 to 28.8), 168 | 29.3 (28.8 to 29.8), 199 | 28.9 (28.4 to 29.4), 176 |
Treatment targets, Dutch guideline for cardiovascular risk management.5 LDL = low-density lipoprotein. BMI = body mass index.